Safe sleep for pediatric inpatients

Janet E Geyer1, Penny K Smith2, Laura R Kair3

  • 1Nursing Practice Leader with the Department of Nursing, University of Iowa Children's Hospital, Iowa City, Iowa, USA.

Insights

Implementing staff education and new equipment significantly improved infant sleep environment safety by reducing loose objects in cribs. Safe sleep positioning was maintained, enhancing overall infant care practices.

Area of Science:

  • Pediatric Patient Safety
  • Quality Improvement in Healthcare
  • Infant Sleep Environment

Background:

  • Inpatient infant environments require rigorous safety protocols.
  • Unsafe sleep conditions pose risks to infant well-being.
  • Previous interventions focused on various aspects of infant care.

Purpose of the Study:

  • To enhance the safety of the sleep environment for infants admitted to the hospital.
  • To evaluate the effectiveness of a bundled intervention on infant sleep safety.

Main Methods:

  • A quality improvement project assessed infant sleep environment safety.
  • Interventions included staff education and provision of swaddle sacks and storage bins.
  • Pre- and post-intervention assessments were conducted.

Main Results:

  • The percentage of infant cribs free of loose objects increased from 32% to 72% (p = .025).
  • Safe sleep positioning rates remained high and stable (82% vs. 95%, p = .183).

Conclusions:

  • Bundled interventions, including education and equipment, improve pediatric inpatient sleep safety.
  • These findings suggest a scalable model for enhancing infant sleep safety in healthcare settings.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
368
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
705
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
664
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
439
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
315
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
2.2K